Clinical trials
Phase 2 Carcinoma, Transitional Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
198 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 8 |
| 2009 | 1 |
| 2010 | 5 |
| 2011 | 4 |
| 2012 | 7 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 6 |
| 2016 | 6 |
| 2017 | 18 |
| 2018 | 16 |
| 2019 | 17 |
| 2020 | 13 |
| 2021 | 14 |
| 2022 | 13 |
| 2023 | 15 |
| 2024 | 9 |
| 2025 | 11 |
| 2026 | 14 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 66 |
| Recruiting | 32 |
| Terminated | 30 |
| Unknown status | 25 |
| Active, not recruiting | 21 |
| Withdrawn | 14 |
| Not yet recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 11 |
| M.D. Anderson Cancer Center | 7 |
| Memorial Sloan Kettering Cancer Center | 6 |
| Fox Chase Cancer Center | 5 |
| Matthew Galsky | 4 |
| National Taiwan University Hospital | 4 |
| Bristol-Myers Squibb | 3 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 3 |
| Incyte Corporation | 3 |
| RemeGen Co., Ltd. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 198 |
| Urinary Bladder Neoplasms | 68 |
| Ureteral Neoplasms | 15 |
| Carcinoma, Non-Small-Cell Lung | 14 |
| Neoplasm Metastasis | 14 |
| Carcinoma, Renal Cell | 13 |
| Urethral Neoplasms | 12 |
| Melanoma | 11 |
| Colorectal Neoplasms | 10 |
| Neoplasms | 9 |
Trials
Showing 51 to 75 of 198. Each trial links to its page on Pharma Observatory.
98 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.